We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




MRSA AI Diagnostics Software Helps Enhance Microbiology Lab Efficiency and Workflow

By LabMedica International staff writers
Posted on 29 May 2023
Print article
Image: BD Kiestra MRSA imaging application helps enhance microbiology laboratory efficiency and workflow (Photo courtesy of BD)
Image: BD Kiestra MRSA imaging application helps enhance microbiology laboratory efficiency and workflow (Photo courtesy of BD)

Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant risk in hospital environments, leading to serious complications like bloodstream or surgical-site infections, sepsis, and even death. Lab tests are necessary to confirm whether an infection is due to MRSA, and the capacity to conduct these tests efficiently and effectively could profoundly influence patient care. However, labs often face hurdles such as fluctuating sample volumes, staff shortages, financial constraints from budget cuts, and shifting diagnostic methods. To address these challenges and facilitate efficient, timely, and cost-effective clinical bacteriological testing, a new solution now offers comprehensive lab automation for clinical microbiology laboratories.

Becton, Dickinson and Company’s (BD, Franklin Lakes, NJ, USA) new BD Kiestra MRSA imaging application employs artificial intelligence (AI) to analyze bacterial growth and release negative samples with minimal human intervention. The BD Kiestra MRSA application employs AI to automate the traditionally laborious and time-consuming task of inspecting Petri dishes to ascertain bacterial growth, allowing medical lab scientists and technicians to devote more time to high-priority analyses.

The application can evaluate individual samples or group together numerous plates showing non-significant growth for batch review and release of negative results, potentially easing the administrative load on technicians. The MRSA imaging application utilizes AI algorithms to identify specific culture characteristics on the BBL CHROMagar MRSA II plate. Based on this information and analysis by BD Synapsys informatics, plate images are automatically arranged and sorted into meaningful worklists for lab scientists and technicians. This AI-driven imaging application, backed by the BD BBL CHROMagar MRSA II screening plates and powered by BD Synapsys Informatics Solution, is compatible with both standalone BD Kiestra ReadA systems and track-based BD Kiestra lab automation solutions.

"The pandemic created significant and ongoing labor challenges in laboratories, and reading plates is a labor-intense, potentially error-prone process in microbiology," said Nikos Pavlidis, vice president and general manager for Diagnostics at BD. "The use of this imaging application to automatically organize specimens in meaningful worklists helps use limited laboratory staff more efficiently and allows lab personnel to bring their expertise to bear on more critical and complex specimens."

Related Links:
BD 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.